Creative Medical Technology Holdings, Inc. (CELZ) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Creative Medical Technology Holdings, Inc. in 2026. The next earnings report is expected on September 2, 2026.
Next earnings date
02 Sep 2026
In 13 days
EPS estimate
-0.39
Revenue estimate
0
Past earnings
No dividend history available.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Creative Medical Technology Holdings, Inc. (CELZ) is scheduled to report earnings on September 2, 2026.
Creative Medical Technology Holdings, Inc. (CELZ) last reported earnings on August 7, 2026.
Creative Medical Technology Holdings, Inc. (CELZ) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.